- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05318703
Virtual Exercise For Older Adults With Mild Cognitive Impairment
March 21, 2023 updated by: Oregon Research Institute
Virtual Exercise Intervention for Older Adults With MCI
This project is designed to develop and evaluate an Internet-based exercise intervention (tai ji quan Moving to Improve Brain Health) using real-time videoconferencing for older adults with mild cognitive impairment (MCI).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The project has three major goals: (a) transforming an in-person tai ji quan brain health intervention protocol into an online (virtual) class protocol and evaluating its feasibility of implementation in older adults with MCI, (b) developing and evaluating online assessment and data ascertainment procedures that encompass cognitive and physical performance measures, and (c) conducting a randomized controlled trial comparing the effectiveness of this new online intervention protocol with a conventional stretching exercise group in older adults with MCI.
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- Oregon Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 95 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- Self-report a change or decline in memory (corroborated by an informant)
- Record a score of ≤0.5 on the Clinical Dementia Rating (CDR) scale (with information derived from both the participant and an informant)
- Show no major impairment in cognitive function as indexed by a score of ≥24 on the Mini Mental State Evaluation (MMSE).
Exclusion criteria:
- Have participated in a rigorous and structured physical activity or exercise program (including Tai Ji Quan) in the past 6 months,
- Show major signs of depression as indicated by a score of ≥5 on the Geriatric Depression Scale
- Have major medical or physical conditions that preclude exercise, as determined by their healthcare practitioner
- Being unable to follow the consent process or sign the study consent form.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: cognitively enhanced tai ji quan
Participants receive a cognitively enhanced tai ji quan exercise intervention for 16 weeks.
|
cognitively enhanced tai ji quan exercise
|
|
Active Comparator: stretching exercise
Participants receive a stretching exercise intervention for 16 weeks.
|
Stretching exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
(a) Total number of intervention sessions taught by instructors over the course of study (recorded by a class check sheet) and (b) total number of classes attended by participants over the course of intervention as recorded by class attendance sheet
Time Frame: 16 weeks
|
assess the extent to which interventionists successfully implement the prespecified exercise training protocol.
|
16 weeks
|
|
number of dropouts from the intervention and study as assessed by a study recording sheet
Time Frame: 16 weeks
|
assess intervention dropout rate and retention rate
|
16 weeks
|
|
Number of participants expressing intervention program satisfaction as assessed by a self-report survey
Time Frame: 16 weeks
|
assess the program acceptability among tai ji quan participants
|
16 weeks
|
|
Change in global cognitive function assessed by Montreal Cognitive Assessment
Time Frame: baseline, 16 weeks
|
assess change from baseline cognitive function at 16 weeks
|
baseline, 16 weeks
|
|
Change in attention and working memory as assessed by Digit Span - forward and backward
Time Frame: baseline, 16 weeks
|
assess change from baseline in attention and working memory at 16 weeks
|
baseline, 16 weeks
|
|
Change in dual-task cost as assessed by Timed Up and Go with a cognitive task
Time Frame: baseline, 16 weeks
|
assess change from baseline in the ability to stand up from a chair, walk, and sit down while performing an arithmetic task at 16 weeks
|
baseline, 16 weeks
|
|
Change in executive function as assessed by Trail Making B
Time Frame: baseline, 16 weeks
|
assess change from baseline executive function at 16 weeks
|
baseline, 16 weeks
|
|
Change in executive function as assessed by Category Fluency for Animals
Time Frame: baseline, 16 weeks
|
assess change from baseline executive function at 16 weeks
|
baseline, 16 weeks
|
|
Change in cognitive functioning assessed by Everyday Cognition
Time Frame: baseline, 16 weeks
|
assess change from baseline cognitive functioning at 16 weeks
|
baseline, 16 weeks
|
|
Change in physical performance as measured by Timed Up and Go test
Time Frame: baseline, 16 weeks
|
assess change from baseline in the ability to stand up from a chair, walk, and sit down at 16 weeks
|
baseline, 16 weeks
|
|
change in leg strength as assessed by 30-second chair stand test
Time Frame: baseline, 16 weeks
|
assess change from baseline in leg strength at 16 weeks
|
baseline, 16 weeks
|
|
Change in balance using a 4-stage balance test
Time Frame: baseline, 16 weeks
|
assess change from baseline in balance at 16 weeks
|
baseline, 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depression as assessed by Geriatric Depression scale
Time Frame: baseline, 16 weeks
|
assess change from baseline in the level of depression at 16 weeks
|
baseline, 16 weeks
|
|
Change in physical activity as assessed by International Physical Activity Questionnaire
Time Frame: baseline, 16 weeks
|
assess change from baseline in physical activity at 16 weeks
|
baseline, 16 weeks
|
|
Change in quality of life as assessed by EuroQol (EQ-5D-3L)
Time Frame: baseline, 16 weeks
|
assess change from baseline in quality of life at 16 weeks
|
baseline, 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2021
Primary Completion (Actual)
August 30, 2022
Study Completion (Actual)
October 30, 2022
Study Registration Dates
First Submitted
March 23, 2022
First Submitted That Met QC Criteria
April 1, 2022
First Posted (Actual)
April 8, 2022
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 21, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AG059546-02S1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
There is a plan to make IPD and related data dictionaries available.
IPD Sharing Time Frame
12 months after the completion of the study.
IPD Sharing Access Criteria
The de-identified data that support the findings of this study are available from the corresponding author upon reasonable request.
Restrictions may apply to preserve participant confidentiality.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.